Webinar Date/Time: Thu, Jul 27, 2023 11:00 AM EDT
Sterile filtration is critical within manybioprocessing steps, upstream and downstream, where performance, safety andquality are important. Discover how filtration manufacturers optimize materialsto maximize performance and integration within single-use systems.
Register Free: https://www.biopharminternational.com/bp_w/filtration
Event Overview:
The focus of this webinar is on sterile filtration and critical filtration parameters that impact integration within single-use systems, including Pre-use Post Sterilization Integrity Testing (PUPSIT) considerations.
Sterile filtration is critical within many bioprocessing steps, upstream and downstream, where product performance and quality are important. Sterile filtration at a retention level of 0.2 micron allows for the removal of microorganisms and/or contaminants from product fluid streams and provides sterile effluents for further processing.
To maximize performance of a filter, a membrane’s parameters and a filter’s form factor design parameters can be optimized for ease of integration into single-use systems. This allows for a single-use assembly to be efficient while minimizing footprint and maximizing performance via connectivity, geometry and function. Single-use design considerations with filtration integration, in PUPSIT for example, are critical and need to be considered for efficient processing. Entegris is a leading filtration manufacturer. Presenters with expertise in the field will discuss the value proposition of optimizing sterile filtration by design and how it integrates into single-use systems while maximizing performance.
Key Learning Objectives
Who Should Attend
Speaker:
Chris Rios
Senior Field Applications Engineer
Entegris Inc.
Chris Rios has 9-plus years’ experience working in Life Sciences with a focus in single-use components and sterile filtration. He has held multiple technical roles supporting end users in bioprocessing and medical device development and has co-developed engineering solutions. Before joining Entegris, Chris worked at Millipore Sigma and Saint-Gobain. He received his Bachelor of Science in Bioengineering and Economics, and is currently pursuing his Master of Science in Bioengineering from George Mason University.
Register Free: https://www.biopharminternational.com/bp_w/filtration
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.